Skip to content

Lexicon Pharmaceuticals

US · LXRX #3430 by market cap
1.76 +0.01 +0.57%
Live - 5344 symbols - heartbeat 418s ago · 2026-10-08 07:40
Pre-market 1.76 0.00%
After-hours 1.76 0.00%
Overnight 1.78 +1.14%
Market cap
783.12M
P/B
4.49
EPS
-0.14
Reader sentiment Are you bullish or bearish on LXRX?

Anonymous reader poll. Unscientific, not investment advice.

Lexicon Pharmaceuticals ended the session at 1.76, up 0.57%. At current prices, the business is worth about 783.12M, the #3430 most valuable US-listed company we track. Wall Street's 4-analyst consensus lands on Buy, with a price target averaging 5.78 (+228% from here). Over the past year the stock has ranged from 1.10 to 2.68; it now sits 42% up that band.

✦ StockVane Quant Insights how this is computed

Quant Rating C Preliminary
  • Not yet in the StockVane Momentum strategy's universe - this name needs price history back to 2021 for a reliable signal and doesn't have it yet (most often because it IPO'd or was spun off more recently). This grade is a preliminary blend of valuation, momentum and analyst data, not a Momentum buy/sell call.
  • Valuation sits at the 37% percentile of its own 5-year range.
  • Price momentum averages -5.0% across the trailing 3-month/1-year windows.
  • Analyst consensus across 4 analysts is Buy.
Quant Sentiment Neutral
  • Recent price momentum is -5.0% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 6.5% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Price chart

2.641.551.762026-04-092026-10-07
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60

Performance

1W -6.38%
1M -21.43%
3M -25.74%
6M +10.00%
YTD +53.04%
1Y +15.79%
3Y +62.96%
5Y -68.29%

Key statistics

Price & volume

Prev close
1.75
Open
1.73
Day range
1.71 - 1.77
Avg price
1.76
Volume
1.10M
Turnover
1.93M
Amplitude
3.22%
52-week range
1.10 - 2.68

Valuation

P/E
-12.57
P/E (TTM)
-11.00
P/B
4.49
EPS
-0.14
Net profit
-62.29M
Net assets
174.42M

Share structure

Market cap
783.12M
Float cap
385.42M
Shares out
444.96M
Float shares
218.99M

Dividend & listing

Dividend (TTM)
0.00
Listing date
--
52-week range 42% of range
1.10 2.68

34.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-3.40M net over the window

Short interest

Shares short
28.79M
As of
2026-09-15

Frequently asked questions

What is the current stock price of Lexicon Pharmaceuticals (LXRX)?

Lexicon Pharmaceuticals last traded at 1.76. The quote on this page refreshes every few seconds while US markets are open.

What is Lexicon Pharmaceuticals's market cap?

About 783.12M.

What is the P/E ratio of Lexicon Pharmaceuticals?

The trailing twelve-month P/E is -11.00. The Valuation tab shows it against the stock's own five-year range.

Does Lexicon Pharmaceuticals pay a dividend?

Lexicon Pharmaceuticals does not currently pay a regular dividend.

Is Lexicon Pharmaceuticals a buy according to analysts?

The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 5.78, which implies 228.4% upside from the current price. This is not investment advice.

Quote time 2026-10-08 07:40:41 · For reference only, not investment advice and not tailored to your situation.